$38.4 Billion U.S. Commercial Weight Loss Market Pivots to Survive GLP-1 Drugs Explosion
The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to ...
Tag: GLP1
$33.8 Billion U.S. Medical Weight Loss Market Now Dominated by GLP-1 Medicine
At no different time within the U.S. weight reduction market historical past has one product so dominated the market as ...
